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Background: Obtaining informed consent is a cornerstone of biomedical research, yet participants
comprehension of presented information is often low. The most effective interventions to improve understanding
rates have not been identified.
Purpose: To systematically analyze the random controlled trials testing interventions to research informed
consent process. The primary outcome of interest was quantitative rates of participant understanding; secondary
outcomes were rates of information retention, satisfaction, and accrual. Interventional categories included
multimedia, enhanced consent documents, extended discussions, test/feedback quizzes, and miscellaneous
methods.
Methods: The search spanned from database inception through September 2010. It was run on Ovid MEDLINE, Ovid
EMBASE, Ovid CINAHL, Ovid PsycInfo and Cochrane CENTRAL, ISI Web of Science and Scopus. Five reviewers working
independently and in duplicate screened full abstract text to determine eligibility. We included only RCTs. 39 out of
1523 articles fulfilled review criteria (2.6%), with a total of 54 interventions. A data extraction form was created in
Distiller, an online reference management system, through an iterative process. One author collected data on study
design, population, demographics, intervention, and analytical technique.
Results: Meta-analysis was possible on 22 interventions: multimedia, enhanced form, and extended discussion
categories; all 54 interventions were assessed by review. Meta-analysis of multimedia approaches was associated with
a non-significant increase in understanding scores (SMD 0.30, 95% CI, -0.23 to 0.84); enhanced consent form, with
significant increase (SMD 1.73, 95% CI, 0.99 to 2.47); and extended discussion, with significant increase (SMD 0.53,
95% CI, 0.21 to 0.84). By review, 31% of multimedia interventions showed significant improvement in understanding;
41% for enhanced consent form; 50% for extended discussion; 33% for test/feedback; and 29% for miscellaneous.
Multiple sources of variation existed between included studies: control processes, the presence of a human proctor,
real vs. simulated protocol, and assessment formats.
Conclusions: Enhanced consent forms and extended discussions were most effective in improving participant
understanding. Interventions of all categories had no negative impact on participant satisfaction or study accrual.
Identification of best practices for studies of informed consent interventions would aid future systematic
comparisons.
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Obtaining informed consent is a key component of bio-
medical research that seeks to uphold the ethical value of
patient and participant autonomy. Yet, the process has
become increasingly burdensome for both researchers
and research participants. Obtaining consent is by no
means simple: researchers must not only enroll partici-
pants in their study, but also convey to them their rights
as human subjects, the scientific question under investi-
gation, the study methodology, and thepotential harms
and benefits. Research staff exert considerable effort
documenting that process.
Research consent typically emphasizes disclosure on
the presumption that more information aids potential
participants in decision-making [1]. A review of the clin-
ical research informed consent literature from 1961 to
2006 revealed that only 54% of patients and research
participants adequately understood the aim of a given
study; 50% understood the process of randomization;
47% understood the nature of voluntariness; 44% under-
stood the ability to withdraw; 50% understood the risks
of the study; and 57% understood the benefits of a study
[2]. Given the premise that the understanding of infor-
mation improves participants’ decision-making capacity,
these results offer a humbling glimpse at what “informed”
currently entails.
In a landscape of expanding biomedical research
methods—such as genomic sequencing, data sharing,
bio-banking, creating pluripotent stem cells, and linking
medical record data with genomic sequence—the need
for effective and efficient consent processes has become
paramount. Since the mid-1990s the National Institutes
of Health (NIH) have invested significant resources on
research studies on the informed consent process. Rec-
ommendations on how to modify existing consent tem-
plates have come from a number of scholars and working
groups [3-9]. Moreover, in July 2011 the Office for Hu-
man Research Protections (OHRP) issued an Advanced
Notice of Proposed Rulemaking (ANPR) to Human Sub-
jects Research Oversight that proposed several important
changes to informed consent under certain conditions.
Most notably, the ANRP called for “…greater specificity
about how consent forms should be written and what in-
formation they should contain.” Researchers and their in-
stitutions, they suggested, should “[create] forms that are
shorter, more readily understood, less confusing, that
contain all of the key information, and that can serve as
an excellent aid to help someone make a good decision
about whether to participate in a study” [10]. The ANPR
may prompt further quality improvement studies about
best practices.
In recent decades bioethics investigators, Institutional
Review Boards, and funders have invested in improving
the informed consent process. These improvementsor enhancements often rely on altering standard paper
consent documents or elements of the process, or
medium in which information is delivered or by which
consent is obtained. For example investigators have
tested enhanced design methodologies [2], multimedia
tools and technologies [11], altered counseling or dia-
logue [12], and the provision of quizzes that give im-
mediate feedback [13]. Many of these efforts aim to
shorten the consent form document and increasing po-
tential participants’ understanding of what was explained
to them.
A recent systematic review could not determine whether
several important consent innovations—those involving
multimedia, extended discussions or immediate feedback
quizzes, had an impact on understanding [14]. However,
small numbers prohibited a full meta-analysis and direct
comparison was not possible due to heterogeneity in study
methodologies and assessment techniques.
Here we report a systematic review of randomized
controlled trials of informed consent interventions for
biomedical research and an accompanying meta-analysis.
Methods
This systematic review and meta-analysis are consist-
ent with existing reporting guidelines (the PRISMA
statement) [15].
Eligibility criteria
We included randomized controlled trials (RCT) that eval-
uated interventions designed to improve the informed con-
sent process for patients and/or research participants.
Studies simulating informed consent process were also in-
cluded, if they were RCT. We excluded all case reports,
single cohort studies, non-randomized trials, review arti-
cles, and other systematic reviews (Figure 1).
Search strategy
An expert reference librarian designed and conducted
an electronic search strategy with input from study in-
vestigators. The search spanned from database incep-
tion through September 2010. The initial search was
run on Ovid MEDLINE using a combination of medical
subject headings (MeSH) and text-words, and then
translated into the terms appropriate to Ovid EMBASE,
Ovid CINAHL, Ovid PsycInfo and Cochrane CENTRAL.
The ISI Web of Science and Scopus databases were
searched as well, using text-words. The primary subject
headings used were “informed consent” or “consent”.
The strategy further focused on formats in which the in-
formation might be delivered: “video recording”, “audio-
visual aid”, “computer-assisted instruction”, “multimedia”,
or “patient education materials”. Outcome and study types
were the final strategy filters: comprehension, readability,
pre-post testing, research design, decision making, patient
Electronic Database Search
MEDLINE, EMBASE, CINAHL, PsycInfo, Cochrane CENTRAL, and ISI Web of Science. 
Performed in November 2009 and September 2010
1523 articles
Abstracts screened for primary eligibility criteria by five reviewers
323 articles
Full articles screened by two reviewers for secondary eligibility criteria
39 articles
Information abstraction performed by AN using custom data form created in DistillerSR.  
Independent cross-check of abstraction data by JBM.
Review: 54 interventions
Meta-Analysis: 22 articles




Figure 1 Flow diagram of results from search process for articles.
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with the bibliography of the most recent and comprehen-
sive systematic review on the topic published in 2004 [14].
Assessment of study eligibility
Four reviewers working independently and in duplicate
screened all abstracts and titles and, upon retrieval of
candidate studies, three team members (JCT, JBM, AN)
reviewed the full text to determine eligibility. If the study
was eligible, data were abstracted by AN. Any questions
arising during data abstraction were resolved by discus-
sion with other team members. JBM conducted an inde-
pendent cross-check.
Data extraction and synthesis
Through an iterative process, we created a standardized
form to extract descriptive, methodological and key vari-
ables from all eligible studies. Distiller (Ottawa, Ontario),
an online reference management system for systematic
reviews, was used to manage study selection and dataextraction. We collected data on study design, population,
demographics, intervention, and analytical technique.
Data were tabulated and categorized according to the
type of intervention. We used categories similar to those
published previously: multimedia, enhanced consent form,
extended discussion, test/feedback, and miscellaneous
methods [14].
Primary outcome: understanding
Our primary outcome was participant understanding/
knowledge. Understanding/knowledge refers to a partici-
pant’s objective comprehension of information conveyed
in the informed consent process, as assessed by quanti-
tative testing methods. Measurements of participants’
perceived levels of understanding were not included in
this study. We further divided understanding into imme-
diate knowledge, knowledge retention, and reading time.
For the purposes of this analysis we defined immediate
knowledge as that tested within one week of the control
or intervention procedure.
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Data regarding the impact of interventions on partici-
pant satisfaction levels or accrual rates were also tracked
and synthesized. Satisfaction rates were determined in
certain studies by quantitative surveys or interviews.
Rates of accrual were tracked based on the actual enroll-
ment of participants into the parent studies associated
with an informed consent intervention. Only actual ac-
crual rates were synthesized in our results. A sufficient
number of actual studies were deemed available to draw
conclusions on accrual.
Other key variables
We also evaluated whether a study had an actual, parent
study with which it was associated; whether the control
and intervention of a study were proctored, or overseen,
by a member of the study team, for example a study
nurse, an investigator, or a research assistant; the sample
size of a trial; the demographics of the study population;
and the methods by which outcomes were assessed. In
addition, we determined whether or not a study had a
“standard control” versus an “enhanced control”. As
control techniques varied between studies, we used
the classification of standard control to delineate those
studies that compared their interventions to a basic,
minimally-altered consent form required by their institu-
tions’ IRB. If a study designated its non-intervention
as either “standard,” “industry standard,” or “legally-
required,” we considered it the control.
Meta-analysis of understanding scores
Due to the difference in the methods of outcome ascer-
tainment (understanding score), we estimated from each
study the standardized mean difference (SMD) and 95%
confidence interval. The SMD is an effect size measure
that is unit-less and can be pooled across studies that
evaluate a similar outcome assessed with different scales.
In all analyses, SMD was estimated as the intervention
understanding scores minus the control understanding
scores (i.e., SMD > 0 favors the intervention group).
Random-effects meta-analysis was used to pool SMDs
across studies because heterogeneity of the subjects,
knowledge content and the design of the studies was
anticipated [16]. Random-effects modeling is a conserva-
tive approach that combines within-study and between-
study variance. We estimated heterogeneity statistically
using the I-squared statistic, which represents the pro-
portion of true heterogeneity that is not attributable to
chance [17]. The reasons for heterogeneity were ex-
plored by conducting a test of interaction based on
whether the intervention group had a proctor, the con-
trol group had a proctor, whether the control group was
an enhanced form of the consent form or just a standard
form, the setting of the study (real vs. simulated) and thetype of subjects (healthy volunteers vs. patients) [18]. To
avoid double counting the control groups of studies with
multiple intervention arms, we tested in sensitivity ana-
lyses the inclusion of each arm and determined if chan-
ging the intervention group affected study conclusions.
Results
Search results
Study selection process is described in Figure 1. In sum,
39 primary articles were reviewed. As some of these arti-
cles tested more than one intervention, we ultimately
tracked the results of 54 interventions: sixteen multi-
media (Table 1), twenty-two enhanced form (Table 2),
six extended discussion (Table 2), three tests/feedback
(Table 3), and seven miscellaneous (Table 4) interventions
were reviewed. In addition to the interventions identified
in the 2004 systematic review [14], we were able to identify
24 additional studies fitting our criteria: six multimedia,
nine enhanced consent forms, four extended discussions,
three tests/feedback, and five miscellaneous.
Results were updated from four multimedia interven-
tions that were previously unpublished and assessed
from a secondary source [19-22]. In the enhanced form
category, two interventions applying different font styles
for the elderly were added. These interventions were
present in a 1987 study by Taub et al. but not in the
2004 review. Another enhanced consent form trial was
updated from a prior secondary source [21]. A test/
feedback intervention was dropped; though it was pre-
viously deemed subject to a randomized trial, it was
only tested on participants who did not score perfectly
on the first iteration of an assessment quiz [23]. Con-
versely, an additional trial, categorized as longitudinal
in the 2004 review, but reassessed by us as randomized
control, was added to the test/feedback category [24].
One trial, previously present in the miscellaneous cat-
egory, was excluded from our primary outcome calcula-
tions as its results were concerned with long-term
retention, rather than immediate understanding [25].
Meta-analysis was feasible with seven multimedia,
eleven enhanced form, and four extended discussion
studies (Figure 2). Remaining studies from all five
categories did not provide their understanding assess-
ment data in a format that could be included in the
meta-analysis.
Traits of the studies
Most of the studies that had a human proctor present for
the control group also had one present for the interven-
tion group. There was one exception in the multimedia
category [19], and several in the extended discussion or
test/feedback categories [20-22]. Less than half of the
multimedia (44%) and enhanced consent (14%) trials had
a human proctor present for the administration of either







Source Intervention Population Scenario Control Intervention P Value
Karunaratne et al.,
2010
Y Interactive computer presentation
replaces consent form. Graphics,
video clips, links, and text styling
Patients with DM Simulated 60 73 82 0.005
Kass et al., 2009
(formerly Agre et al.
2003)
N Digital touch-screen presentation
on oncology clinical research
replaces brochure
Patients with cancer Real 130 17 34 0.03‡
Bickmore et al., 2009 Y° Standard consent form with
explanation by interactive,
computerized “agent”
Healthy volunteers Simulated 18 39 42 NS
Hack et al., 2007 N° Supplementary take-home
audiotape recording of
standardized study details°
Patients with cancer Real 42 88 85 NS∞
N° Supplementary take-home
audiotape recording of IC
consultation and second audiotape
of standardized study details°
Patients with cancer Real 47 88 87 NS∞
Hutchinson et al.,
2007
Y° Supplementary 10 min. video.
Vignettes, visual aids, voice-over,
and graphics. Patients allowed to
take video home°
Patients with cancer Real 173 NA NA 0.011§,∞
Mittal et al., 2007 N° Powerpoint slideshow on computer
replaces consent form. Graphics,





Simulated 35 52 60 NS
Wirshing et al., 2005
(formerly Agre et al.
2003)
N Video with specific study guidelines
replaces generic video on human
research. Professionally acted









Y Video replaces consent form.





Simulated 120 47 50 NS
Y Computer presentation replaces
consent form. Video and still





Simulated 118 47 51 NS†
Agre and Rapkin,
2003






Real 209 68 66 NS






Real 221 68 73 NS
Dunn et al., 2003
(includes Dunn
et al., 2001)
Y° Powerpoint slideshow replaces
consent form. Altered
organization, layout and





Real 99 85 91 0.014
Fureman et al.,
1997
N° Supplementary 26 min. video.
Talkshow format with expert
panel answering audience
questions°
Injection drug users Real 186 81 80 NS
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filmed 10 min. video°
Pregnant women Simulated 90 91 95 NS
Llewellyn- Thomas
et al., 1995
Y Standard consent form in
navigable, digital format
Patients with cancer Simulated 100 81 79 NS
Abbreviations: NA not Available; NS Not significant; DM diabetes mellitus.
Bolded rows indicate trials include in the 2004 systematic review by Flory and Emanuel.
° Human proctor available for question/answer.
§ P-value is a based on change in pre-consent and post-consent quiz scores.
†P-value is a post hoc calculation of the total scores contrasting all combinations of formats; Understanding scores based on averages of high and low-risk
protocol arms.
‡ Only relates to participant’s ability to identify purpose of the study.
∞ Understanding assessed at approximately 1 week.
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interventions had a proctor, while the enhanced discussion
and test/feedback interventions all had human proctors.
Forty-four percent of the interventions were tested
under real, as opposed to simulated, conditions. All test/
feedback interventions had real parent studies, whereas
only seven enhanced form interventions were in real
scenarios (31%). All newly tested enhanced form inter-
ventions since 2004 were in simulated trials. Multimedia,
extended, and miscellaneous studies were split in their
extent of being tested under real conditions (50%, 50%,
and 40%, respectively).
Assessment formats varied widely between studies, in-
cluding in-person or telephone questionnaires [23-30], or
computer- and paper-based quizzes. Certain studies
tested in an open-book format [19], allowing participants
access to trial information, while most studies required
participants to work from memory alone. The number of
questions within a test ranged from 8 to 80, with ques-
tion types including True/False, Yes/No, multiple choice,
open-ended, and prompted recall. As seen in Tables 1, 2,
3, 4 and 5, some studies had mean understanding scores
for both control and intervention below 50%, while
others had these scores both in the upper 80th per-
centile. Such variation suggests a potential difference
in assessment difficulty between trials. While some as-
sessment methods were validated for their respective
study populations through pilot methods, validation for
the population under study was not a consistent feature
for all methods.
Impact of different consent innovations on understanding
Multimedia
Meta-analysis of multimedia-based consent approaches
showed a non-significant increase in understanding scores
compared with control consent approaches (SMD 0.32,
95% CI, -0.20 to 0.85). Heterogeneity of this analysis was
substantial (I2 = 90%). Results are depicted in Figure 2.
Subgroup analyses (Table 6) were not statistically signifi-
cant and did not provide an explanation of the observed
substantial heterogeneity. Due to this heterogeneity, themeta-analysis results should be tempered with contextual
data from the component studies.
Several contextual details of the control procedures
and intervention design of the studies included in the
meta-analysis are of note. Three of the included trials
had non-standard controls. Mittal et al. sought to test
the feasibility of two interventions (multimedia and en-
hanced consent form) for a larger trial [31]. They speci-
fied no control, but the data allowed us to assign the
enhanced form as a non-standard control. Hack et al.
compared two types of audiotape supplements, but nei-
ther were compared to a tapeless scenario [32]. Agre
and Rapkin compared several interventions to a consent
form that was modified to read at the 8th grade level
[33]. Relatedly, Bickmore et al. tested an interactive
computer-based proctor against two different proce-
dures: the participant read an informed consent docu-
ment alone or the participant was led through consent
process by a human proctor. We included the data
comparing the computer-based proctor (intervention)
to the human proctor (control), which showed no sig-
nificant difference. Yet, both the computer and human
proctors were comparably more effective than the read-
alone scenario for patients with adequate health literacy
(p = 0.006) [19]. Finally, as noted elsewhere [34], the
multimedia intervention tested by Llewellyn-Thomas
et al. in 1995 was merely a standard consent form
presented on a computer screen, representing variability
in what the category of “multimedia” entails [35].
Six additional studies were reviewed but not included
in the meta-analysis due to the absence of requisite data
in their published results. Fureman et al. and Weston
et al. had non-significant results for immediate under-
standing, though their interventions improved retention
rates [36,37]. While the intervention of Kass et al. signifi-
cantly improved understanding rates, our review relied
on only one question from the assessment: the ability of
a participant to identify the purpose of the study [23].
Campbell et al. tested an intervention in two different the-
oretical trials, one involving a high-risk protocol; the other
low-risk [26]. We averaged the results for both, which were







Source Intervention Population Scenario Control Intervention P Value




Simulated 115 67 69 NS
Y Simplified paper document
developed by a working group of




Simulated 114 67 69 NS
Campbell et al.,
2008
N Simplified text in booklet format
with color. 7th grade reading level
Healthy volunteers Simulated 146 64 85 <0.001
Walters and Hamrell,
2008
Y Simplified paper document. 6th
grade reading level
Healthy volunteers Simulated 317 77 79 NS*
Paris et al., 2007 Y Simplified paper document with
systematic readability improvement
Healthy volunteers Simulated 99 78 82 ≤0.05
Y Simplified paper document
developed by a working group of
clinical research nurse, IRB member,
and healthy volunteer
Healthy volunteers Simulated 101 78 83 ≤0.017
Y Simplified paper document
developed by a working group
and by systematic readability
improvement
Healthy volunteers Simulated 100 78 82 ≤0.05
Campbell et al.,
2004
Y Simplified paper document with




Simulated 119 47 53 NS
Agre and Rapkin,
2003
N Simplified paper document
presented in booklet form with





Real 221 69 70 NS
Coyne et al., 2003 Y° Simplified paper document with
revised text styling, page layout,
and language. 7th grade reading
level. Organized in Q/A format°
Patients with cancer Real 207 69 72 NS‡
Dresden and
Levitt, 2001
N Simplified paper document with
revised layout, text styling, and
language
Patients in the E.R. Simulated 100 72 88 <0.0001
Stiles et al., 2001 Y° Simplified paper document with




Simulated 227 81 81 NS
Bjorn et al., 1999 N Leaflet used by pharmacology
company with revised language,
style and layout. Hypertension
scenario
Healthy volunteers Simulated 135 48 56 <.05
N Leaflet used by pharmacology
company with revised language,
style and layout. Sterilization
scenario
Healthy volunteers Simulated 100 NA NA NS
Murphy et al., 1999 N Simplified paper document. 6th
grade reading level with text
styling and illustrations
Women at risk for
HIV
Simulated 141 70 83 0.0001
Davis et al., 1998 Y Revised with patient input,
readability improved from





Simulated 183 56 58 NS
Rogers et al., 1998 Y° Consent required to “opt out”
of study, rather than “opt in”°
Recent mothers Real 44 30 47 <0.02
Nishimura et al. BMC Medical Ethics 2013, 14:28 Page 7 of 15
http://www.biomedcentral.com/1472-6939/14/28
Table 2 Results of trials with enhanced consent form intervensions (Continued)
Taub et al., 1987 Y Simplified paper document. 7th
grade reading level
Elderly volunteers Real 235 68 70 NS
N Standard or simplified paper
document with “Letter Gothic”,
enlarged font
Elderly volunteers Real 235 71 65 NS*
N Standard or simplified paper
document with “Orator”,
enlarged all-caps font
Elderly volunteers Real 235 71 70 NS
Taub et al., 1986 Y Simplified paper document.
7th grade reading level
Patients with heart
disease
Real 188 71 74 NS
Epstein and
Lasagna, 1969
Y Simplified paper document.
Shorter with succinct phrasing
Hospital Employees Simulated 44 45 67 <.001
Abbreviations: NA Not Available, NS Not Significant, DM diabetes mellitus, OSAS obstructive sleep apnea syndrome, HIV human immunodeficienc virus.
Bolded rows indicate trials included in the 2004 systematic review by Flory and Emanuel.
°Human proctor available for question/answer.
* Significant improvement reported for eldest cohorts.
‡ Understanding assessed within approximately 1 week.
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found strong demographic predictors in intervention effi-
cacy [38]. The team compared a specialized video to a gen-
eral IRB video with university students, Veterans Affairs
(VA) patients, and patients with schizophrenia. While all
showed significant improvement in understanding post-
intervention, the students benefited the most. Results from
other studies included data for populations with mental ill-
nesses [31,38,39], history of injecting drug use (IDU) [36],
and varying stress levels [33].
Based on the entire review, and not just meta-analysis,
five of the sixteen total multimedia interventions (31%)




Sarkar et al., 2010 Y° Standardized, focus group discussion




Freer et al., 2009 Y Information leaflet and supplementary,
standardized discussion with study staff°
Paren
Kingd
Y Information leaflet and supplementary,




Y° Same presentation formats.
Supplementary telephone




Y Supplementary conversation with
enrolling physician°
Patien
Simes et al., 1986 Y° Uniform consent procedure ensuring
total disclosure of information by
physicians°
Patien
Abbreviations: NA Not Available, NS Not Significant, HIV human immunodeficiency v
Bolded rows indicate trials included in the 2004 systematic review by Flory and Emanu
°Human proctor available for question/answer.
* P value is for the overall outcomes which include "willingness to participate" and
§ Scores based on an “awareness scale” in an interview format after approximately
∞ Understanding assessed at approximately 1 week.Enhanced consent form
Meta-analysis showed that the enhanced consent form
category was associated with significant increase in un-
derstanding scores compared with control consent ap-
proach (SMD 1.73, 95% CI, 0.99 to 2.47). Heterogeneity
of this analysis was substantial (I2 = 97%). Results are
depicted in Figure 2. Subgroup analyses (Table 6) demon-
strated that the improvement in understanding scores
was larger in simulation studies (vs. real-setting studies)
and in studies in which neither study arm (intervention
or control) had a human proctor. These subgroup inter-





lation Scenario Control Intervention P Value
s of malnourished
n in Vellore, India
Real 118 73 73 NS
ts in United
om
Simulated 21 69 85 0.015
s in United States Simulated 20 66 75 NS
ts with cancer Real 230 66 83 <.001§
ts with HIV Real 113 60 63 NS∞













Intervention Population Scenario Control Intervention P Value
Eyler et al.,
2004
Y Supplementary, scripted Q/A by study staff
throughout narration. Staff provided correct
answer immediately after posing question°
Patients with mental
illness
Real 24 57 68 NS
Y Supplementary, scripted Q/A by study staff
throughout narration. Staff provided correct
answer after patient answered a question°
Patients with mental
illness
Real 32 57 67 NS
Taub et al.,
1983
N° Participant asked to repeat knowledge quiz
(up to three times) if any questions were
answered incorrectly°
Elderly volunteers Real 100 69 89 <.01
Abbreviations: NA Not available, NS Not significant, Q/A Question and answer.
°Human proctor available for question/answer.
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of a proctor, other factors may have impacted study het-
erogeneity in the meta-analysis. One variation included
the risk factors and medical literacy of a study’s sample
demographic. Epstein and Lasagna’s study population
was composed primarily of medical employees [40].
Three other studies included populations that had men-
tal illness [41], low literacy levels [27], or low-incomeFigure 2 Meta-analysis of interventions reviewed.levels [42]. Another source of heterogeneity is the way
in which researchers assessed participant understanding.
Unlike the paper-based testing formats used by most
studies, Rogers et al. used an interview-based assessment
technique [43]. Though the impact of this technique is
unclear, it is correlated with markedly lower scores for
both control and intervention cohorts than in other
studies (Table 2).







Source Intervention Population Scenario Control Intervention P Value
Tait et al., 2010 N Online presentation in which tables,
instead of text, are used to explain
risk vs benefit
Parents Simulated 3139 49∞ 45∞ NS
N Online presentation in which
pictographs, instead of text are used
explain risk vs benefit
Parents Simulated 3094 49∞ 67∞ <.05
Ford et al., 2008 Y° Standard paper document read aloud




Real 136 48 52 0.012‡
Lavori et al., 2007 Y° Supplementary self-assessment for
study staff after each consent
discussion with a participant°
Patients and healthy
volunteers
Real 836 78 79 NS
Agre et al., 2003






Simulated 206 NA NA NS






Simulated 227 82 81 NS
Wragg et al., 2000 N Simplified paper document and video
with physician explanation. Material
written to express current facts without
stressing importance of the trial
Female research
participants
Simulated 100 51 49 NS
Abbreviations: NA Not Available, NS Not Significant.
Bolded rows indicate trials included in the 2004 systematic review by Flory and Emanuel.
°Human proctor available for question/answer.
‡ Understanding assessed at approximately 1 week.
∞Scores represent the percent of sample who scored >5 out of 7, which they called adequate knowledge.
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one had significant results. Bjorn et al. used a leaflet
intervention for two different study scenarios. For the
scenario involving a theoretical hypertension study, the
results were significant, but for a sterilization scenario,
results were non-significant [44]. Campbell et al., Agre
and Rapkin, Coyne et al., Davis et al. and Taub et al. all
had non-significant results. However, Agre and Rapkin,
as with their trial of a multimedia intervention, used a
control form with improved readability potentially de-
creasing the perceived effectiveness of the intervention
[33]. Murphy et al. saw significant improvement with
their intervention, but only for a specific population of
low-income women at-risk for HIV [42] Taub et al. fo-
cused primarily on an elderly population, finding little
significant improvement except for when an enlarged
font was used for the eldest cohort [45].
Overall, nine out of twenty-two enhanced consent in-
terventions (41%) showed significant improvement in
the review.
Extended discussion, test/feedback, and miscellaneous
The approach of using extended discussion was associated
with significant increase in understanding scores compared
with control consent approach (SMD 1.03, 95% CI, 0.79to 1.26). Heterogeneity of this analysis was minimal
(I2 = 35%). Results are depicted in Figure 2. Subgroup
analyses (Table 6) demonstrated that the improvement in
understanding scores was larger in real-setting studies
(vs. simulation studies). These subgroup interactions par-
tially explain the minimally observed heterogeneity.
Studies not included in the meta-analysis for this cat-
egory of intervention showed varied results. Sarkar et al.
tested a focus group intervention with parents in rural
India, finding no significant improvement [13]. Aaronson
et al., conversely, found significant improvement with extra
phone conversations [29]. Both studies assessed outcomes
with an interview-style format. Simes et al. reported posi-
tive results after providing a check-list to ensure physicians
had a comprehensive disclosure discussion with trial pa-
tients [46]. For all studies, in both meta-analysis and re-
view, three of six (50%) extended discussion interventions
had a significantly positive impact on understanding.
Of the two new test/feedback interventions, neither
showed significant improvement in understanding [22].
However, an intervention reassessed in this review as part
of a randomized control trial did show a significantly posi-
tive effect [24]. None of the other interventions from the
2004 review were randomized, thus they were not included
in this analysis. In total, one-third of the test/feedback
Table 6 Subgroup interactions for meta-analysis of
interventions
Multimedia vs. control
# of studies SMD LL UL p-value
Control
Nonstandard 3 0.23 −0.41 0.88 0.8
Standard 4 0.37 −0.45 1.19
Overall 7 0.29 −0.22 0.8
Proctor present for control?
No 1 0.57 0.17 0.97 0.65
Yes 5 0.37 -0.44 1.17
Proctor present for intervention?
No 2 0.51 0.14 0.88 0.85
Yes 4 0.41 -0.52 1.34
Subjects
Patients 4 0.69 0.14 1.25 0.33
Volunteers 1 0.16 -0.76 1.09
Setting
Real 4 0.12 -0.65 0.89 0.25
Simulated 3 0.64 0.22 1.06
Enhanced consent form vs. control
# of studies SMD LL UL p-value
Control
Nonstandard 3 2.33 0.01 4.66 0.49
Standard 8 1.47 0.7 2.23
Proctor present in both groups?
No 7 2.6 1.33 3.88 0.01
Yes 2 0.33 -0.43 1.09
Subjects
Patients 4 2.56 0.69 4.44 0.59
Volunteers 5 1.94 0.66 3.23
Setting
Real 3 0.57 -0.06 1.19 0.01
Simulated 8 2.23 1.19 3.28
Extended discussion vs. control
# of studies SMD LL UL p-value
Proctor present in control group?
No 3 1.31 0.33 2.29 0.19
Yes 1 0.63 0.33 0.93
Subjects
Patients 2 1.33 -0.07 2.74 0.53
Volunteers 2 0.83 0.19 1.47
Setting
Real 1 2.06 1.61 2.52 0.01
Simulated 3 0.66 0.39 0.93
Abbreviations: SMD Standard mean deviation, LL Lower limit, UL Upper limit.
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cant improvement.
Two of the five new miscellaneous interventions showed
significant improvement in understanding [47,48]. While
Flory and Emanuel presented one of three randomized tri-
als with significant improvement (33%) [14], we observed
improvement in two out of seven total trials (29%).
Sensitivity analysis
Four studies in the meta-analysis had multiple interven-
tion arms [32,49-51]. The choice of intervention arm did
not affect the overall conclusions of this meta-analysis.
Impact of different consent innovations on satisfaction,
accrual and retention
There is little to no indication that the interventions
tested in these trials negatively impact participant satis-
faction or study accrual. Data regarding rates of partici-
pant satisfaction were tracked for eleven interventions.
Preferences between interventions and controls were ei-
ther insignificant or showed that participants significantly
preferred the interventions [19,27,29,32,35,43,47,52-54].
Accrual rates, tracked for trials with real parent studies,
were also reported as improved or unchanged by inter-
ventions in all categories [13,23,29,43,52,55,56], with one
exception [46]. These findings are consistent with those
discussed in the 2004 review [14].
Ten studies that tested an intervention’s impact on un-
derstanding also tested for impact on knowledge retention;
interventions in all categories except extended discussion
and test/feedback showed an overall positive impact on
rates of knowledge retention. The seven interventions in
the multimedia and enhanced form categories significantly
improved knowledge retention rates [25,36,37,50]. Three
interventions in the other categories had insignificant re-
sults for retention [24,46,48].
An additional five studies tested seven different inter-
ventions’ impact on retention, but not immediate under-
standing. Of these studies, all found significantly positive
impacts from their interventions. These studies included
three enhanced forms [53], one test/feedback [57], and
three miscellaneous interventions [55,58,59].
Discussion
Different types of intervention to improve research con-
sent across a variety of settings show mixed impact on
improving participant knowledge. The search and data
abstraction for this paper adds twenty-four interven-
tions, tested in randomized control trials, to Flory and
Emanuel’s 2004 systematic review. In addition, this first
of its kind meta-analysis, notwithstanding the stated lim-
itations, demonstrates that enhanced consent forms, ex-
tended discussion, and multimedia interventions favor
improved knowledge outcomes. Only enhanced consent
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nificant in changing the outcome; the consistency
of multimedia’s effectiveness remains unclear. Finally,
there is little evidence that a participant’s satisfaction
or a study’s accrual rates would be negatively altered
by attempts to improve the informed consent process,
which should be reassuring to investigators. Our find-
ings confirm those from other previously performed
systematic reviews. However, they may not be applic-
able to illiterate or socially disadvantage groups, given
the limits of our search, indicating an important do-
main for more research.
Our data highlight several key points. First, both the
form and the conversation are important for the process.
Secondly, the effect of multimedia in the informed con-
sent process remains in question. However, as found in
the 2004 review, it may prove useful in helping with
long-term knowledge retention [14]. This element of
learning may promote other dimensions of participant
autonomy such as voluntariness: if a participant better
remembers what a study is about, he or she can better
decide whether to stay enrolled. Moreover, we speculate
that multimedia may serve to compliment discussion
and written forms to simultaneously address immediate
and long-term understanding. Defining the role of multi-
media will be increasingly critical as media-based tech-
nology becomes cheaper to implement, more accessible
and more transportable (e.g., iPads).
Still, even the most exquisitely-designed form, be it on
paper or computer screen, should not be expected to
suffice. Arguably there is still no substitute for a good
conversation, which facilitates opportunities for ques-
tions and interaction cannot be underestimated. An in-
teresting and novel focus for improving consent could
be creating interventions designed explicitly on improv-
ing communication skills Our data suggest that if the re-
search enterprise could move towards a practice of rich
conversations between investigator and participant, sev-
eral crucial points would be addressed. Participants may
have a better understanding of the study, they would
likely feel more like a “partner” in the research process,
they could be easily exposed to a natural test/feedback
setting, and a relationship between the participant and
the researcher would be established. We found that ex-
tended discussions had the most consistent result of im-
proving understanding, although only 50% showed
significant improvement. No category of intervention
managed to have consistent efficacy.
The question of whether “shorter forms are better
than longer forms” – at least whether “shorter is no
worse than longer” for participant understanding – is
still an open question, pointing to the need for studies
that directly compare a “short form” intervention to a
traditional “long form” control in a randomized controlsetting. Whether short forms coupled with conversation
would potentiate even greater increases in understand-
ing is a hypothesis for future consent research.
The efficacy of test/feedback interventions is difficult
to discern at this point. Most test/feedback trials fall eas-
ily into the format of a pseudo-randomized or cohort
study as only the participants who fail a first assessment
proceed to take a second (or third) assessment. Re-
searchers must devise more stringent methodologies
to ensure that their studies are fully legitimate ran-
domized experiments.
Limitations
Our study has several limitations. We restricted our
search to interventions tested in RCT trials in order to
meet the general gold standard of a systematic review.
Yet, others have suggested that certain complex, socially-
embedded biomedical activities are restricted by the lens
of an RCT [60]. The informed consent process may be
such an activity and may find ample aid from other more
qualitative or observational studies. In addition, our study
is limited by the primary outcome we sought to inves-
tigate: understanding. We were focused on objective
assessments of participant understanding. Rates of un-
derstanding are important under the presumption that
more information aids potential participants in decision-
making [1]. Information-based decision-making aims to
demonstrate respect for individual participants’ autonomy.
However, there are other ethical values that may be equally,
if not more, important to participants. For example, the
values of trust and honesty may be more significant to par-
ticipants who are willing to enter a trial based on their phy-
sicians’ recommendations. Truly informed consent may
thus entail more than simply comprehending and memor-
izing information.
Several features of our analysis reveal the need for stan-
dardized research on informed consent interventions.
The controls used in the studies we analyzed were highly
varied. In some studies the control consent process was
similar to standard practice. Usually, this process in-
volved a long, paper-based document at the 12th grade
(or higher) reading level [56]. In other studies, the con-
trol was an already enhanced version of the standard
form. For example, Mittal et al.’s control form was a well-
designed, formatted brochure revised to read at the 8th
grade reading level [31]. One would expect the improve-
ments in understanding—over the control—for trials with
enhanced control formats to be less significant than those
with standard control formats. In some cases, the control
cohort did not have any form, likely amplifying the re-
sults of the intervention [25]. Thus, side-by-side com-
parison of these different interventions may be unfair.
Heterogeneity across these trials was the norm for
assessing understanding. The wide ranges in normalized
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suggest that the varied choice of approach across studies
may contribute to perceived level of understanding.
While all trials included are interested in a participant’s
level of understanding after the consent process, the
different testing formats produced varied results. As-
sessments differed drastically in format, question-type,
length, and provision and this heterogeneity among as-
sessments hinders direct comparison. Standardized, veri-
fied examinations have been developed specifically for
the informed consent process, yet only several studies
in our review made use of them. For example, the
MacCAT-CR, BICEP and QuIC are all pre-established
assessment tools that were used in several studies
[19,31,48]. However, the majority of studies used custom-
created assessment forms. While a number of teams
determined the reliability of their tests through pilot
versions or other means, the inconsistency between dif-
ferent trials still precludes an accurate comparison. Just
as the composition of an informed consent document
may impact understanding levels, so too may assess-
ment methods impact the degree to which participants
can express their knowledge. This issue is particularly
relevant for populations with low-literacy levels. Com-
paring results between trials with strongly divergent as-
sessment techniques is problematic and limits the value
of systematic reviews.
Additional variations between studies that limit com-
parison have been discussed by previous authors. The
categories with the most positive outcomes, enhanced
discussion and test-feedback, were also the categories
with the fewest number of studies [14]. Few adequate
criteria exist for tracking study quality; there are vast dif-
ferences between population demographics; and cat-
egories for interventions group disparate interventions
together. In 2009, Henry et al. focused in depth on
each study in Flory and Emanuel’s multimedia category,
exposing how almost every study could be interpreted
differently than it was in the systematic review. They
agreed with the authors of a Cochrane review of multi-
media informed consent interventions: “the empirical
literature is not yet sufficiently developed to draw de-
finitive conclusions one way or the other about the
general effectiveness of or value derived from multi-
media consent aids” [11,61]. We agree with this conclu-
sion of Henry et al. and Ryan et al. and further
extended its implications to include all of the interven-
tion categories. Perhaps more important than our find-
ings for improving the consent process are our findings
for improving the study of the consent process.
Despite these limitations and potential theoretical
flaws, our research contributes an important body of
data to the study of understanding in the informed con-
sent process.Conclusions
We report on a systematic review of 54 interventions
and meta-analysis of 22 interventions that sought to im-
prove the rates of participant understanding in the
informed consent process. The attention to research in-
formed consent in recent years highlights the need for
up-to-date, concise summaries of effective consent strat-
egies. However, such summaries have thus far remained
elusive. Furthermore, in an area of increased attention to
consent for genomic research and bio-banking, knowing
the state of the literature on effective consent strategies
is essential. In an attempt address these needs, we report
a systematic review of randomized controlled trials of in-
formed consent interventions for biomedical research
and an accompanying meta-analysis.
The findings of our study suggest that enhanced con-
sent forms and extended discussions are most effective
in improving participant understanding. Multimedia in-
terventions are effective, though not significantly so, and
appear to be more useful for improving long-term know-
ledge retention rates. Interventions involving test/feedback
quizzes may be effective, but studies are too sparse to cur-
rently draw useful conclusions. Miscellaneous interven-
tions do not appear to consistently improve understanding,
though studies of such interventions are also sparse.
For many of the people who do research with human
participant, obtaining informed consent is viewed as a
legal and ethical hurdle that stands in the way of the real
study of interest. Guidelines for research informed consent
need to be cost-effective for researchers and institutions to
implement. The most accessible route to providing useful,
applicable evidence on better research informed consent
process to researchers obtaining consent is by standardiz-
ing how studies on informed consent are conducted. Such
standardization (or streamlining) need not diminish or
eliminate creativity with interventions developed to en-
hance the informed consent process, but rather should be
done in a way that will allow for comparisons of interven-
tions in meta-analysis and systematic reviews.
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